Lehrstuhl für Strahlentherapie

Reliability of determining the resectability of locally progressed pancreatic ductal adenocarcinomas - results from the CONKO-007 multicenter randomized controlled trial (EudraCT:2009-014476-21) (2018) Wittel UA, Golcher H, Gruetzmann R, Bechstein WO, Belyaev O, Uhl W, Ghadimi M, et al. Conference contribution Low-dose irradiation has an impact on bone metabolism as well as on local and systemic immune cell-mediated inflammation (2018) Deloch L, Rückert M, Seeling M, Nimmerjahn F, Fietkau R, Frey B, Gaipl U Conference contribution Radio(chemo)therapy does differently impact on PD-L1 and PD-L2 expression in human melanoma cell lines (2018) Derer A, Riegel D, Frey B, Fietkau R, Gaipl U Conference contribution Radiosensitizing and radioprotecting effect of kinase-inhibitor Palbociclib in different normal tissue and cancer cell lines (2018) Jost T, Hecht M, Fietkau R, Distel L Conference contribution Pretreatment vitamin D levels are associated with improved overall survival following combined chemoradiotherapy (2018) Putz F, Distel L, Lettmaier S, Weissmann T, Filimonova I, Fietkau R Conference contribution Mechanism of necrotic Cell Clearance by non-professional Phagocytes (2018) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution Proliferating non-professional Phagocytes are able to generate Cell-in-Cell Structures (2018) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution Kinase Inhibitor Palbociclib shows differential Effects upon Irradiation on Normal Tissue and Cancer Cell Lines (2018) Jost T, Proebstle S, Buerkel F, Hecht M, Fietkau R, Distel L Conference contribution Low-Dose Radiotherapy Has No Harmful Effects on Key Cells of Healthy Non-Inflamed Joints (2018) Deloch L, Rückert M, Fietkau R, Frey B, Gaipl U Journal article, Original article Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment (2018) Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article